ACADIA Pharmaceuticals Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
968.63 |
1,063.15 |
1,182.17 |
1,327.95 |
1,466.72 |
1,662.77 |
| Przychód Δ r/r |
0.00% |
9.76% |
11.20% |
12.33% |
10.45% |
13.37% |
| Przychód (min) |
962.46 |
1,032.77 |
1,119.40 |
1,327.94 |
1,419.29 |
1,609.00 |
| Przychód (max) |
974.27 |
1,103.65 |
1,332.22 |
1,327.96 |
1,562.03 |
1,770.82 |
| EBITDA (średnia) |
-273.36 |
-300.03 |
-333.62 |
-374.76 |
-413.92 |
-469.25 |
| EBIT (średnia) |
-281.43 |
-308.89 |
-343.48 |
-385.83 |
-426.15 |
-483.11 |
| EBIT % |
-29.05% |
-29.05% |
-29.05% |
-29.05% |
-29.05% |
-29.05% |
| Zysk netto (średni) |
228.88 |
84.22 |
142.59 |
252.32 |
323.87 |
419.31 |
| Zysk netto % |
23.63% |
7.92% |
12.06% |
19.00% |
22.08% |
25.22% |
| EPS (średnia) |
0.72 |
0.51 |
0.81 |
1.44 |
1.95 |
2.52 |
| Liczba analityków (Przychody) |
15 |
13 |
18 |
15 |
6 |
11 |
| Liczba analityków (EPS) |
13 |
12 |
14 |
13 |
9 |
11 |
| symbol |
ACAD |
ACAD |
ACAD |
ACAD |
ACAD |
ACAD |